The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
Please take the time to complete the Physician Practice Information Survey! If you or your…
Impacting allergy immunotherapy vial preparation, USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations went…
On November 1, 2023, the new chapter of USP General Chapter <797> was implemented. AAOA has…
12/01/24: Research Grant Cycle
Learn more
04/01/25: Fellow Exam Application Deadline
Learn more
06/01/25: Research Grant Cycle
Learn more
08/08/25: Scientific Abstract Submission Deadline
Learn more
Thanks to your feedback, we have reimagined our Advanced Course in Allergy & Immunology to give you educational programming that encompasses your full scope of practice. Join us for the new Explorers Course 2025: Surgical & Medical Management of Airway Disease in Otolaryngology. Learn More
We are pleased to invite you to participate in the 2025 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2025 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
Explorers Course 2025:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
90-days Access Feb 27 – May 30, 2025
March 27-29, 2025 - Live
The Hythe, Vail, CO
Learn More and Register
2025 AAOA Basic Course in Allergy & Immunology - Hybrid
90-days Access June 10 – Sep 15, 2025
July 10-12, 2025 - Live
The Chateaux Deer Valley, Park City, UT
Book Your Room
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available Now!
Are you missing rare eosinophilic disease diagnoses? Join an expert multidisciplinary panel for a podcast…
Are you missing rare eosinophilic disease diagnoses? Join an expert multidisciplinary panel for a podcast…
Join Drs. Puchalski, Baker and Wilson as they discuss the value of AAOA Membership. https://youtu.be/ZMhleLO-bsM…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
by Jami Lucas, AAOA CEO/Executive Director Over 500 AAOA members were engaged, learning, and networking with each other in New Orleans. This is fabulous! Your AAOA leadership and staff team embarked on an Annual Meeting Re-Design effort for Chicago 2017. …
2019 New Orleans was an outstanding success? With over 500 participants, our AAOA members left New Orleans re-energized, re-freshed, and re-engaged. The program offered something for everyone — from cutting edge clinical content to every day how to’s for practice…
Alpen Patel, MD, FAAOA is currently serving as 2019-2020 AAOA President. https://www.youtube.com/watch?v=WGGN1HewAsI AAOA's 2019-2020 President, Alpen Patel, MD, FAAOA Learn more about Alpen Patel, MD, FAAOA here.
Join us in the Lone Star State for the 2019 AAOA Advanced Course in Allergy and Immunology. This course builds on the basic clinical care of allergic patient concepts and techniques presented at the AAOA’s Basic Course in Allergy &…
Read top articles published in the International Forum of Allergy & Rhinology 2018-2019. Most Cited International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis February 2018 Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double‐blinded placebo‐controlled trial for…
re·im·ag·ineverb reinterpret (an event, work of art, etc) imaginatively; rethink Reimagined, Reinvented, Reinvigorated….these are all fervently used terms to help define how our world and our day-to-day activities are challenging us to rethink relevancy and how to make even simple…
"Food allergy is a costly, potentially life-threatening health condition that can adversely affect patients’ well-being". A study of 40 443 US adults, published in the medical journal JAMA Network Open, estimates that nearly 19 percent of adults think they have food allergies, but approximately…
The Food and Drug Administration (FDA) has approved ProAir Digihaler (albuterol sulfate) inhalation powder for the treatment or prevention of bronchospasm in patients aged 4 years and older with reversable obstructive airway disease, and for prevention of exercise-induced bronchospasm (EIB)…
...the AAOA continues to be the organization that Otolaryngologists look to for up-to-date education and information on the practice of Allergy. I attended my first AAOA Course 20 years ago and have witnessed significant changes in how we diagnose and treat allergic disease. Older diagnostic and…
The Food and Drug Administration approves the first generic version of EpiPen and EpiPen Jr. FDA Commissioner Scott Gottlieb, M.D states that “This approval means patients living with severe allergies who require constant access to life-saving epinephrine should have a…
